Glioma Immunology and Immunotherapy
- 1 April 2000
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurosurgery
- Vol. 46 (4), 778-792
- https://doi.org/10.1227/00006123-200004000-00002
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- Dendritic cells: from ontogenetic orphans to myelomonocytic descendantsImmunology Today, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary reportJournal of Neuro-Oncology, 1995
- Complete regression of anaplastic astrocytoma by intravenous tumor necrosis factor-alpha (TNFα) after recurrence: A case reportSurgical Neurology, 1994
- Intracranial administrations of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumorsJournal of Neuro-Oncology, 1994
- Recent advances in immunobiology of brain tumorsJournal of Neuro-Oncology, 1993
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Allogeneic tumor-specific cytotoxic T lymphocytesCancer Immunology, Immunotherapy, 1992
- Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: Growth characteristics, cytolytic activity, and cell phenotypeCancer Immunology, Immunotherapy, 1991
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987